1.345
Schlusskurs vom Vortag:
$1.335
Offen:
$1.33
24-Stunden-Volumen:
319.73K
Relative Volume:
0.92
Marktkapitalisierung:
$156.06M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-3.10M
KGV:
-0.0822
EPS:
-16.3657
Netto-Cashflow:
$-1.93M
1W Leistung:
+3.46%
1M Leistung:
-2.54%
6M Leistung:
-13.78%
1J Leistung:
-56.14%
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Vergleichen Sie SXTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SXTC
China Sxt Pharmaceuticals Inc
|
1.345 | 154.90M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
China Sxt Pharmaceuticals Inc Aktie (SXTC) Neueste Nachrichten
Chinese Stocks To ConsiderNovember 19th - MarketBeat
What sentiment indicators say about China SXT Pharmaceuticals Inc. stockWeekly Profit Analysis & Fast Entry and Exit Trade Plans - newser.com
How China SXT Pharmaceuticals Inc. (2RY) stock reacts to fiscal policies2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Volume spikes in China SXT Pharmaceuticals Inc. stock – what they mean2025 Winners & Losers & High Accuracy Trade Alerts - newser.com
How strong dollar benefits China SXT Pharmaceuticals Inc. (2RY) stockWeekly Market Outlook & Safe Entry Trade Signal Reports - newser.com
Using portfolio simulators with China SXT Pharmaceuticals Inc. includedJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
Why China SXT Pharmaceuticals Inc. (2RY) stock attracts HNW investorsWeekly Profit Summary & Weekly Momentum Picks - newser.com
How buyback programs support China SXT Pharmaceuticals Inc. (2RY) stockJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
Will China SXT Pharmaceuticals Inc. (2RY) stock hit analyst forecastsInsider Selling & Stock Portfolio Risk Management - newser.com
How China SXT Pharmaceuticals Inc. (2RY) stock performs during market turbulenceLong Setup & Risk Controlled Daily Trade Plans - newser.com
Will China SXT Pharmaceuticals Inc. (2RY) stock recover faster than industryChart Signals & Momentum Based Trading Ideas - newser.com
How China SXT Pharmaceuticals Inc. stock reacts to Fed rate cutsEarnings Risk Summary & Real-Time Volume Spike Alerts - newser.com
Is China SXT Pharmaceuticals Inc. stock a smart buy before Fed meetingTrade Volume Report & Weekly High Potential Stock Alerts - newser.com
Top Chinese Stocks To Keep An Eye On – November 17th - Defense World
Long term hold vs stop loss in China SXT Pharmaceuticals Inc.2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Will China SXT Pharmaceuticals Inc. stock recover after recent dropMarket Performance Report & Precise Buy Zone Tips - newser.com
China SXT Pharmaceuticals Inc. recovery potential after sell offJobs Report & Short-Term Swing Trade Alerts - newser.com
How China SXT Pharmaceuticals Inc. (2RY) stock behaves in tightening cyclesWeekly Gains Summary & Weekly Sector Rotation Insights - newser.com
Top Chinese Stocks To Keep An Eye OnNovember 17th - MarketBeat
Promising Chinese Stocks To Watch TodayNovember 13th - MarketBeat
Why China SXT Pharmaceuticals Inc. (2RY) stock is upgraded to buy2025 Big Picture & AI Forecasted Stock Moves - newser.com
What Sector Trends Benefit Electronics Mart India Limited Stock in YEARHigh Dividend Yield Stocks & Download Your Free Wealth Map PDF - earlytimes.in
Best Chinese Stocks To Watch Today – November 15th - Defense World
What drives China SXT Pharmaceuticals Inc stock priceRSI Overbought/Oversold & Free ETF and Mutual Fund Comparisons - earlytimes.in
Finanzdaten der China Sxt Pharmaceuticals Inc-Aktie (SXTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):